ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more – FirstWord Pharma
- ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more FirstWord Pharma
- Radiopharmaceutical added to stereotactic radiation can delay prostate cancer progression Medical Xpress
- Day 1 Highlights from ASTRO 2025 by Drew Moghanaki Oncodaily
- Mayo Clinic experts present key radiation oncology findings at ASTRO Mayo Clinic News Network
- UCLA presents advances in radiation therapy at ASTRO 2025 News-Medical